Navigation Links
Boca Pharmacal Contributes to a Healthier Haiti
Date:5/1/2013

CORAL SPRINGS, Fla., May 1, 2013 /PRNewswire/ -- Boca Pharmacal, Inc., today announced that it successfully donated 18,814 bottles of prescription multivitamins to Haiti in conjunction with Christian Aid Ministries, a nonprofit 501(c)(3) organization that helps the needy throughout the world. Perhaps more importantly, the company has also been successful in seeing that the products are getting to where they are needed – in clinics and hospitals on the island.  

(Photo: http://photos.prnewswire.com/prnh/20130501/FL05454-a)

(Logo: http://photos.prnewswire.com/prnh/20130501/FL05454LOGO-b)

"This has been a long time coming," said Robert Edwards , CEO of Boca Pharmacal. "After the earthquake hit Haiti in 2010, we felt compelled to help out and get medicine to the orphanages and clinics that were in need. The logistics turned out to be a tremendous challenge. The learning curve was high and it took time to figure out how to get the medication directly to the people who needed them the most. We've learned a lot about the supply chain and are encouraged about what we'll be able to do moving forward."

Boca Pharmacal is donating U.S. FDA-approved products that – while safe and effective – are typically destroyed by American companies because of limited dating or cosmetic imperfections.

"We see about 130 patients every day and vitamins are a large part of our therapy for those lacking in proper nutrition," said a representative of the Haiti Health Ministries in Leogane, Haiti. "One of our patients, Madame Dorelien, had been feeling weak lately and lacking in energy. The doctor prescribed a multivitamin for her. We are hopeful that this, in addition to eating properly, will bring her back to health."

Mr. Edwards is currently in the process of forming a nonprofit 501(c)(3) and is actively working with generic drug manufacturers to expand the program. He encourages other pharmaceutical companies interested in making large-scale pharmaceutical product donations to contact his team for information on how to participate.

Boca Pharmacal, Inc.
Since its beginnings in 1998, Boca Pharmacal's mission has been to offer niche items that were overlooked by some of the larger generic companies as affordable alternatives to brand-named products.

Using multiple facilities across the globe, Boca Pharmacal has a broad reach and a reliable vertical structure that allows them to develop products that include tablets and capsules, semi-solids, solutions, and suspensions. They continue to invest in research and development to make sure they're providing their clients with a wide variety of offerings. The Boca Pharmacal product line is marketed to chains, wholesalers, distributors, managed markets and government agencies. Boca Pharmacal is located at 3550 NW 126th Avenue, Coral Springs, Florida, 33065. For more information, visit www.bocapharmacal.com.

Images available upon request.CONTACT:

Jennifer MouraBoca Pharmacal3550 NW 126th AveCoral Springs, FL 33065Phone: (954) 346-8810Email: info@bocapharmacal.com


'/>"/>
SOURCE Boca Pharmacal, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mission Pharmacal Company Continues Its Support of March for Babies
2. Mission Pharmacal Company Introduces Prednisolone Sodium Phosphate Oral Solution 25mg/5mL
3. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
4. Texas A&M Research Contributes To Improved Ultrasound Imaging
5. Ansell and Child in Hand Announce Completion of Critical Community Projects in Haiti
6. Sae-A Trading Sponsors Medical Mission to Haiti
7. BD and Heart to Heart International Collaborate on Second Volunteer Service Trip to Help Improve Healthcare in Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 23, 2017  Directors from Pharma To Market Pty Ltd and ... forces, resulting in the founding of Pharma To Market Pte Ltd, ... Market are pleased to announce their expansion into Asia ... Singapore . The company are delighted to appoint Joelle ... Singapore based entity. Joelle brings with her ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):